Showing 1-4 of 4 grants
| Title | Institution | Researcher | Program | Duration | Total Award Amount |
|---|---|---|---|---|---|
| Bioengineered Islet Organs to Accelerate Clinical Translation in T1D (BIO-ACT) | Università Vita-Salute San Raffaele | Lorenzo Piemonti | Cures | 01-February-2026 to 31-January-2029 | $1,519,453.20 |
| Critical Quality Attributes (CQAs)-Guided Selection of GMP-Compliant iPSC Lines for β Cell Replacement Therapy | Università Vita-Salute San Raffaele | Lorenzo Piemonti | Cures | 01-February-2026 to 31-January-2028 | $358,418.00 |
| Impact of NK cells on the outcome of transplantation in patients with Type 1 Diabetes | Università Vita-Salute San Raffaele | Lorenzo Piemonti | Cures | 01-January-2023 to 31-December-2026 | $699,918.00 |
| Late pre-clinical validation of safety and long-term functionality of hypoimmunogenic iPSC-derived β cells into fully humanized transgenic mouse model of Type 1 Diabetes. | Università Vita-Salute San Raffaele | Lorenzo Piemonti | Cures | 01-December-2024 to 30-November-2027 | $999,995.70 |